New drugs and drug combinations are helping more patients live longer with advanced kidney cancer. But questions remain about how best to choose among them.

by Kendall K. Morgan

People with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment.

by Kate Yandell

Facts and Stats

New treatments in the U.S. are scrutinized in various ways before and after they are approved by the Food and Drug Administration.

by Bradley Jones

In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?

by Anna Goshua

African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.

by Jon Kelvey

Nonprofits provide support to young cancer patients in need of fertility preservation, and a childhood cancer survivor joins the first all-civilian mission to space.

by Bradley Jones

Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.

by Kevin McLaughlin

Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.

by Anna Goshua

Research measures regret about treatment among African Americans with prostate cancer, and COVID-19 vaccination recommendations for cancer patients are released.

by Marci A. Landsmann

Two extremely rare cases of cancer being passed from mother to child observed in Japan, and advice on COVID-19 vaccines for cancer patients.

by Bradley Jones